Search

everythinglearnresearchcommunity

for

Search:↓

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.